Baker D C, Haskell T H, Putt S R
J Med Chem. 1978 Dec;21(12):1218-21. doi: 10.1021/jm00210a009.
A number of 5'-(O-acyl) derivatives of 9-beta-D-arabinofuranosyladenine (ara-A, VIRA-A) (2a-k) were prepared by direct acylation of the parent nucleoside 1 in pyridine-N,N-dimethyliformamide. These compounds, designed as prodrugs for 1, offer a range of solubilities and lipophilicities indicating for several examples improved solubility and the potential for improved membrane transport over 1. All are resistant to deactivation by adenosine deaminase. Of special interest is the 5'-(O-valeryl) derivative 2d that shows a marked increase in antiviral activity over 1.
通过在吡啶 - N,N - 二甲基甲酰胺中对母体核苷1进行直接酰化反应,制备了一系列9-β-D-阿拉伯呋喃糖基腺嘌呤(阿糖腺苷,VIRA - A)(2a - k)的5'-(O-酰基)衍生物。这些化合物被设计为1的前药,具有一系列的溶解度和亲脂性,例如其中几个显示出溶解度的提高以及与1相比膜转运改善的潜力。所有这些化合物都对腺苷脱氨酶失活具有抗性。特别令人感兴趣的是5'-(O-戊酰基)衍生物2d,其抗病毒活性比1有显著提高。